Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 79-86

  Hallsworth, Matthew P ^a   Giembycz, Mark A ^b   Barnes, Peter J ^b   Lee, Tak H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Apoptosis; Cell survival; Cyclic AMP; Cytokine; Eosinophil; GM CSF; Signal transduction

Indexed keywords

5 (4 ACETAMIDOPHENYL) 2(1H) PYRAZINONE; BUCLADESINE; CELL DNA; CHOLERA TOXIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIBUTYRYL CYCLIC GMP; DNA FRAGMENT; FORSKOLIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE INHIBITOR; ROLIPRAM;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030058812     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15157.x     Document Type: Article

References (51)

1. BOURNE, H.R., LICHTENSTEIN, L.M. & MELMON, K.L. (1972). Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3′,5′-adenosine monophosphate in human leukocytes, J. Immunol., 108, 695-705.
2. BOUSQUET, J., CHANEZ, P., LACOSTE, J.Y., BARNÉON, G., GHAVANIAN, N., ENANDER, J., VENGE, P., AHLSTEDT, S., SIMONY-LAFONTAINE, J., GODARD, P. & MICHEL, F.B. (1990). Eosinophilic inflammation in asthma. N. Engl. J. Med., 323, 1033-1039.
3. 2+ independent and accompanied by induction of tyrosine kinase activity. J. Leukocyte Biol., 53, 347-353.
4. BURKE, L., HALLSWORTH, M.P., LITCHFIELD, T.M., DAVIDSON, R. & LEE, T.H. (1991). Identification of the major activity derived from cultured human peripheral blood mononuclear cells, which enhances eosinophil viability, as granulocyte-macrophage colony stimulating factor (GM-CSF). J. Allergy Clin. Immunol., 88, 226-235.
5. COX, J.P. & KARNOVSKY, M.L. (1973). The depression of phagocytosis by exogenous cyclic nucleotides, prostaglandins, and theophylline. J. Cell Biol., 59, 480-490.
6. DENT, G., GIEMBYCZ, M.A., EVANS, P.M., RABE, K.F. & BARNES, P.J. (1994). Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta-adrenoceptor agonist albuterol. J. Pharmacol. Exp. Ther., 271, 1167-1174.
7. DFNT, G., GIEMBYCZ, M.A., RABE, K.F. & BARNES, P.J. (1991). Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan stimulated respiratory burst by "type IV"-selective PDE inhibitors. Br. J. Pharmacol., 103, 1339-1346.
8. DOWNES, C.P., HAWKINS, P.T. & IRVINE, K.F. (1986). Inositol 1,3,4,5-tetrakisphosphate and not phosphatidylinositol 3,4-bisphosphate is the probable precursor of inositol 1,3,4-trisphosphate in agonist-stimulated parotid gland. Biochem. J., 238, 501-506.
9. DUNHILL, M.S. (1960). The pathology of asthma with special reference to changes in bronchial mucosa. J. Clin. Pathol., 13, 27-33.
10. DURHAM, S.R. & KAY, A.B. (1985). Eosinophils, bronchial hypereactivity and late phase asthmatic reactions. Clin. Allergy, 15, 411-418.
11. FRANKLIN, W. (1974). Treatment of severe asthma. N. Engl. J. Med., 299, 1469-1472.
12. FRIGAS, E. & GLEICH, G.J. (1986). The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol., 77, 527-537.
13. GIEMBYCZ, M.A. & BARNES, P.J. (1993). Stimulus-response coupling in eosinophils: receptors, signal transduction and pharmacological modulation. In (Immunopharmacology of Eosinophils . ed. Smith, H. & Cook, R.M. pp. 91-118. London: Academic Press.
14. HANSEL, T.T., DE VRIES, I.J.M, IFF, T., RIHS, S., WADZILAK, M., BETZ, S., BLASER, K. & WALKER, C. (1991). An improved immunological procedure for the isolation of highly purified human blood eosinophils, J. Immunol. Methods, 145, 105-110.
15. HARVATH, L., ROBBINS, J.D., RUSSELL, A.A. & SEAMON, K.B. (1991). Cyclic AMP and human neutrophil chemotaxis: elevation of cyclic AMP differentially affects chemotactive responsiveness. J. Immunol., 146, 224-232.
16. HATZELMANN, A., TENOR, H. & SCHUDT, C. (1995). Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions. Br. J. Pharmacol., 114, 821-831.
17. HORN, B.R., ROBIN, E.D., THEODORE, J. & VAN KESSEL, A. (1975). Total eosinophil counts in the management of bronchial asthma. N. Engl. J. Med., 292, 1152-1155.
18. 4 generation by human eosinophils stimulated by ionophore (A23187) as granulocyte-macrophage colony stimulating factor (GM-CSF). Am. Rev. Respir. Dis., 140, 1340-1347.
19. IGNARRO, L.J. & GEORGE, W.J. (1974). Mediation of the immunologie discharge of lysosomal enzymes from human neutrophils by guanosine 3′,5′-monophosphate. Requirement of calcium, and inhibition by adenosine 3′,5′-monophosphate. J. Exp. Med., 140, 225-238.
20. KATO, H., ISHITOYA, J. & TAKENAWA, T. (1986). Inhibition of inositol phospholipid metabolism and calcium mobilization by cyclic AMP-increasing agents and phorhol ester in neutrophils. Biochem. Biophys. Res. Commun., 139, 1272-1278.
21. KITA, H., ABU-GHAZALEH, R.I., GLEICH, G.J. & ABRAHAM, R.T. (1991). Regulation of Ig-induced eosinophil degranulation by adenosine 3′,5′-cyclic monophosphate. J. Immunol., 146, 2712-2718.
22. LANOTTE, M., RIVIERE, J.B., HERMOUET, S., HOUGE, G., VINTERMYR, O.K. GJERTSFN, B.T. & DOSKELAND, S.O. (1991). Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase 1 in a myeloid leukemia cell line. J. Cell. Physiol., 146, 73-80.
23. 2+ by cAMP in vascular smooth muscle cells. Am. J. Physiol., 258, C399-407.
24. LOWELL, F.C. (1967). Clinical aspects of eosinophilia in atopic disease. J. Am. Med. Assoc., 202, 875-878.
25. MACCONKEY, D.H., ORRENIUS, S. & JONDAL, M. (1990). Agents that elevate cyclic AMP stimulate DNA fragmentation in thymocytes. J. Immunol., 145, 1227-1230.
26. MARINI, M., AVONI, E., HOLLEMBORG, J. & MATTOLI, S. (1992). Cytokine mRNA profile and cell activation in bronchoalveolar lavage fluid from nonatopic patients with symptomatic asthma. Chest, 102, 661-669.
27. MATTOLI, S., MATTOSO, V.L., SOLOPERTO, M., ALLEGRA, I. & FASOLI, A. (1991). Cellular and biochemical characteristics of bronchoalvcolar lavage fluid in symptomatic nonallergic asthma. J. Allergy Clin. Immunol., 87, 794-802.
28. MILLER, S.A., DYKES, D.D. & POLESKY, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
29. MONACO, L., VICTNI, E. & CONTI, M. (1994). Structure of two rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases. Multiple mRNA variants originate from alternative splicing and multiple start sites. J. Biol. Chem., 269, 347-357.
30. 4. J. Pharmacol. Exp. Ther., 268, 139-143.
31. NIELSON, C.P. (1987). Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation. J. Immunol., 139, 2392-2397.
32. NOURSHARGH, S. & HOULT, J.R.S. (1986). Inhibition of human neutrophil degranulation by forskolin in the presence of phosphodiesterase inhibitors. Eur. J. Pharmacol., 122, 205-212.
33. RIVKIN, I., ROSENBLATT, J. & BECKER, E.L. (1975). The role of cyclic AMP in the chemotactic responsivencss and spontaneous motility of rabbit peritoneal neutrophils: the inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. J. Immunol., 115, 1126-1134.
34. ROBINSON, D.S., YING, S., BENTLEY, A.M., MENG, Q., NORTH, J., DURHAM, S.R., KAY, A.B. & HAMID, Q. (1993). Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms and airway methacholine responsiveness in atopic asthma. J. Allergy Clin. Immunol., 92, 397-403.
35. ROTHMAN, B.L., KENNURE, N., KELLEY, K.A., KATZ, M. & AUNE, T.M. (1993). Elevation of intracellular cyclic AMP in human T lymphocytes by an anti-CD44 mAb. J. Immunol., 151, 6036-6042.
36. SCHWARTZ, J.P. & PASSONEAU, J.V. (1974). Cyclic AMP-mediated induction of the cyclic AMP phosphodiestcrase of C-6 glioma cells. Proc. Natl. Acad. Sci. U.S.A., 71, 3844-3848.
37. SHAMON, K.B., PADGETT, W. & DALY, J.W. (1981). Forskolin: Unique diterpene activator of adenylate cyclase. Proc. Natl. Acad. Sci. U.S.A., 78, 3363-3367.
38. SEDGWICK, J.B., BERUBE, M.L. & ZURIER, R.B. (1985). Stimulus dependent inhibition of superoxide generation by prostaglandins. Clin. Immunol. Immunopathol., 34, 205-215.
39. SMITH, J.W., STEINER, A.L., NEWBERRY, W.M. & PARKER, C.W. (1971). Cyclic adenosine 3′,5′-monophosphate in human lymphocyte alterations after phytohemagglutinin stimulation. J. Clin. Invest., 50, 432-441.
40. SOUNESS, J.E., CARTER, C.M., DIOCHEE, B.K., HASSEL, G.A., WOOD, L.J. & TURNER, N.C. (1991). Characterisation of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem. Pharmacol., 42, 973-945.
41. SOUNESS, J.E., VILLAMIL, M.E., SCOTT, L.C., TOMKINSON, A., GIEMBYCZ, M.A. & RAEBURN, D. (1994). Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Br. J. Pharmacol., 111, 1081-1088.
42. SOUSA, A.R., POSTON, R.N., LANE, S.J., NAKHOSTEEN, J.A. & LEE, T.H. (1993). Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis., 147, 1557-1561.
43. STERN, M., MEAGHER, L., SAVILL, J. & HASLETT, C. (1992). Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol., 148, 3543-3549.
44. TAI, P.C., SUN, L. & SPRY, C.J.F. (1991). Effects of IL-5, granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol., 85, 312-316.
45. 2, forskolin, and dibutyryl cyclic AMP on arachidonic acid metabolism in guinea pig neutrophils. J. Biol. Chem., 261, 1092-1098.
46. TAYLOR, K.J. & LUKSZA, A.R. (1987). Peripheral blood eosinophil counts and bronchial hyperresponsiveness. Thorax, 42, 452-456.
47. TORPHY, T.J., ZHOU, H.-L. & CIESLINSKI, L.B. (1992). Stimulation of beta-adrenoceptors in a human monocyte cell line (U937) upregulates cyclic AMP-phosphodiesterase activity. J. Pharmacol. Exp. Ther., 263, 1195-1205.
48. TYAGI, S.R., OLSEN, S.C., BURNHAM, D.N. & LAMBETH, J.D. (1991). Cyclic AMP-elevating agents block chemoattractant activation of diradylglycerol generation by inhibiting phospholipase D activation. J. Biol. Chem., 266, 3498-3504.
49. WILLIAMS, G.T., SMITH, C.A., SPOONCER, E., DEXTER, T.M. & TAYLOR, D.R. (1990). Haemopoetic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 343, 76-79.
50. WYLLIE, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
51. YOUSEFI, S., GREEN, D.R., BLASER, K. & SIMON, H-U. (1994). Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. U.S.A., 91, 10868-10872.